Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain

dc.contributor.authorTrino Baptista
dc.contributor.authorYamily ElFakih
dc.contributor.authorEuderruh Uzcátegui
dc.contributor.authorIgnacio Sandia
dc.contributor.authorEduardo Tálamo
dc.contributor.authorEnma Araujo de Baptista
dc.contributor.authorSerge Beaulieu
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:02:18Z
dc.date.available2026-03-22T21:02:18Z
dc.date.issued2008
dc.descriptionCitaciones: 115
dc.identifier.doi10.2165/00023210-200822060-00003
dc.identifier.urihttps://doi.org/10.2165/00023210-200822060-00003
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85560
dc.language.isoen
dc.publisherAdis, Springer Healthcare
dc.relation.ispartofCNS Drugs
dc.sourceUniversity of the Andes
dc.subjectPsychopharmacology
dc.subjectAntipsychotic
dc.subjectAtypical antipsychotic
dc.subjectMedicine
dc.subjectClozapine
dc.subjectNeurology
dc.subjectPsychiatry
dc.subjectSchizophrenia (object-oriented programming)
dc.subjectRisperidone
dc.subjectBipolar disorder
dc.titlePharmacological Management of Atypical Antipsychotic-Induced Weight Gain
dc.typereview

Files